2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow CT-P6: new trials by email Literature Review of CT-P6 trials Research Report on CT-P6
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer Anastrozole, Denifanstat, Exemestane - Advanced Breast Carcinoma, HER2-Positive Breast Carcinoma | Phase 2 | Completed | Mayo Clinic | 17 | 2017-08-03 | 2026-10-09 |
| Evaluate Safety, Efficacy and Pharmacokinetics CT-P6, Herceptin, Paclitaxel - Metastatic Breast Cancer | Phase 1 / Phase 2 | Completed | Celltrion | 143 | 2010-02-01 | 2025-01-24 |
Breast Neoplasms (1)
Celltrion (1) · Mayo Clinic (1)
South Korea (1) · United States (1)
Investigational Site (1) · Tufia C. Haddad, M.D. (1)